Faithward Advisors LLC increased its stake in Bristol Myers Squibb Company (NYSE:BMY – Free Report) by 7.7% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,855 shares of the biopharmaceutical company’s stock after buying an additional 349 shares during […]

UniSuper Management Pty Ltd lifted its position in shares of Bristol Myers Squibb Company (NYSE:BMY – Free Report) by 4.3% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 134,358 shares of the biopharmaceutical company’s stock after purchasing an additional 5,600 shares during […]

Clark Capital Management Group Inc. grew its position in shares of Bristol Myers Squibb Company (NYSE:BMY – Free Report) by 0.9% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 951,143 shares of the biopharmaceutical company’s stock after acquiring an additional 8,085 shares during […]

Banque Transatlantique SA raised its stake in shares of Bristol Myers Squibb Company (NYSE:BMY – Free Report) by 50,952.3% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,005,730 shares of the biopharmaceutical company’s stock after acquiring an additional 1,003,760 […]

AQR Capital Management LLC lifted its position in Bristol Myers Squibb Company (NYSE:BMY – Free Report) by 49.0% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 5,969,030 shares of the biopharmaceutical company’s stock after buying an additional 1,962,233 shares during the period. AQR Capital Management […]

Cigna Investments Inc. New trimmed its position in Bristol Myers Squibb Company (NYSE:BMY – Free Report) by 1.9% during the first quarter, Holdings Channel reports. The institutional investor owned 20,383 shares of the biopharmaceutical company’s stock after selling 398 shares during the quarter. Cigna Investments Inc. New’s holdings in Bristol Myers Squibb were worth $1,243,000 […]

Oarsman Capital Inc. lifted its position in shares of Bristol Myers Squibb Company (NYSE:BMY – Free Report) by 36.3% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 35,640 shares of the biopharmaceutical company’s stock after buying an additional 9,483 shares during the quarter. […]

Warwick Investment Management Inc. acquired a new stake in Bristol Myers Squibb Company (NYSE:BMY – Free Report) in the 1st quarter, Holdings Channel.com reports. The fund acquired 3,312 shares of the biopharmaceutical company’s stock, valued at approximately $202,000. Other hedge funds and other institutional investors also recently modified their holdings of the company. Commonwealth Equity […]

D L Carlson Investment Group Inc. purchased a new stake in shares of Bristol Myers Squibb Company (NYSE:BMY – Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 24,763 shares of the biopharmaceutical company’s stock, valued at approximately $1,510,000. […]